Search bioRxiv⌕ Search

Biology subjects

Nguyen, T. T.-P.

Publications and source records attributed to Nguyen, T. T.-P..

2 recordsLinked to original sources

Structural basis of quinone-sensing by the MarR-type repressor MhqR in Staphylococcus aureus

The MarR-family regulator MhqR of Staphylococcus aureus (SaMhqR) was previously characterized as quinone-sensing repressor of the mhqRED operon. Here, we resolved the crystal structures of apo-SaMhqR and the 2-methylbenzoquinone (MBQ)-bound SaMhqR complex. AlphaFold3 modelling was used to predict the structure of the SaMhqR in complex with its operator DNA. In the DNA-bound SaMhqR state, S65 and S66 of an allosteric 3-4 loop adapted a helically wound conformation to elongate helix 4 for optimal DNA binding. Key residues for MBQ interaction were identified as F11, F39, E43, and H111, forming the MBQ-binding pocket. MBQ binding prevented the formation of the extended helix 4 in the allosteric loop, leading to steric clashes with the DNA. Molecular dynamics (MD) simulations revealed an increased intrinsic dynamics within the allosteric loop and the {beta}1/{beta}2-wing regions after MBQ binding, to prevent DNA binding. Using mutational analyses, we validated that F11, F39, and H111 are required for quinone sensing in vivo, whereas S65 and S66 of the allosteric loop and D88, K89, V91 and Y92 of the {beta}1/{beta}2-wing are essential for DNA binding in vitro and in vivo. In conclusion, our structure-guided modelling and mutational analyses identified a quinone-binding pocket of SaMhqR and the mechanism of SaMhqR inactivation, which involves local structural rearrangements of an allosteric loop and a high intrinsic dynamics to prevent DNA interactions. Our results provide novel insights into the redox-mechanism of the conserved SaMhqR repressor, that functions as an important determinant of quinone and antimicrobial resistance in S. aureus. IMPORTANCES. aureus is a major human pathogen, which can cause life-threatening infections in humans. However, treatment options are limited due to the prevalence of antimicrobial resistant isolates in the hospital and the community. The MarR-type repressor SaMhqR was described to control resistance towards quinones and quinone-like antimicrobials. However, the redox-regulatory mechanism of SaMhqR by quinones was unknown. In this work, we explored the DNA-binding and quinone-sensing mechanism of SaMhqR and identified a quinone-binding pocket and an allosteric loop, which facilitates DNA binding activity via a helical wound conformation and adapts an unstructured coiled conformation upon quinone binding to inhibit DNA binding. A similar mechanism has been recently discovered for regulation of uric acid resistance by UrtR family repressors (1). Our results contribute to a better understanding of antimicrobial resistance regulation, which can be exploited for future drug-design to eradicate multidrug-resistant S. aureus.

microbiology↗

The co-localizing Zorya II, Druantia III, and ARMADA II defense systems on O-island 172 confer synergistic anti-phage defense in enterohemorrhagic Escherichia coli

In this study, we show that the enterohemorrhagic Escherichia coli (EHEC) strain EDL933 {Delta}stx1/2 is highly resistant to phages. The genes encoding the three phage defense systems Zorya II, Druantia III, and ARMADA II were found to co-localize on O-island 172 (OI-172) in EDL933. The three phage defense systems co-occur in 426 E. coli strains comprising 66 distinct serotypes, including 277 O157:H7 isolates and 117 diverse non-pathogenic strains. Efficiency of plating (EOP) assays were used to explore the phage spectrum and synergy of the three defense systems and their contribution to the phage resistance of strain EDL933 {Delta}stx1/2. Using {Delta}zorABE, {Delta}druHE, and {Delta}armABCD single system deletion mutants in EDL933 {Delta}stx1/2, we showed that Druantia III and ARMADA II protect to different extents against a broad spectrum of phages, including the Drexlerviridae, Siphoviridae, Demerecviridae, Vequintavirinae and Autographiviridae, but not against hypermodified Tevenvirinae. Additionally, Zorya II caused strong protection only against Autographiviridae. Furthermore, EOP assays of combined system mutants revealed strong synergistic interactions of Druantia III and ARMADA II to provide more robust immunity against a similar phage spectrum than the additive protection of the individual systems. In contrast, Druantia III and Zorya II act only weakly synergistically against a few phages. Altogether, our results revealed that Druantia III and ARMADA II are responsible for most of the phage resistance of EDL933 {Delta}stx1/2, whereas Zorya II provides additional immunity against podoviruses. Future studies are underway to elucidate the molecular basis of the synergistic interactions between the Druantia III and ARMADA II defense systems. IMPORTANCEShiga toxin-producing E. coli (STEC) O157:H7 strains cause life-threatening diseases, such as hemorrhagic colitis and the hemolytic uremic syndrome. Currently, EHEC infections can be only treated symptomatically, since antibiotics are not recommended due to induction of the Shiga toxin. While phage therapy could offer a treatment option, we show that the EHEC strain EDL933 {Delta}stx1/2 is highly resistant to many phages. EOP assays of defense mutants in the host strain revealed that the co-occurring defense systems Zorya II, Druantia III, and ARMADA II on OI-172 confer most of the phage resistance in EHEC. Moreover, our data uncovered that Druantia III and ARMADA II act synergistically in the anti-phage defense in EDL933 {Delta}stx1/2, explaining the robust immunity against a broad spectrum of phages. These results support the idea that the design of novel inhibitors against the Druantia III and ARMADA II systems could be combined with phage therapies to efficiently eradicate EHEC.

microbiology↗